Stargardt Disease Clinical Trials

45 clinical trials for Stargardt Disease across international registries, including 20 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Phase 1 Study of C.001 in Retinal Degeneration — RECRUITING · PHASE1
• A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults — RECRUITING
• A Study of AAVB-039 in Participants With Stargardt Disease (STGD1) — RECRUITING · PHASE1
• Study of ALK-001 on the Progression of Stargardt Disease — RECRUITING · PHASE3
• Stem Cell Ophthalmology Treatment Study II — RECRUITING · NA
• Inherited Retinal Degenerative Disease Registry — RECRUITING
• A Phase 1/2, First-in-Human, Open-label, Assessor-Masked, Randomized, Controlled, Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects with Stargardt Disease (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ATP Binding Cassette Subfamily A Member 4 (ABCA4) Gene (ASTRA). — RECRUITING · PHASE2
• Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease — RECRUITING · PHASE1
• An Open-Label, Single-Arm, 3-Year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Subjects with Stargardt Disease — RECRUITING · PHASE3
• Restoration of Central Vision With PRIMA in Patients With Photoreceptor Degeneration — RECRUITING · NA
• Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD) — RECRUITING
• Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH) — RECRUITING
• A Study of DC6001 Tablet in Healthy Chinese Adult Subjects — RECRUITING · PHASE1
• Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR) — RECRUITING · PHASE1
• The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration — RECRUITING · PHASE1
• An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene — RECRUITING
• A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1) — RECRUITING · PHASE1
• Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease — RECRUITING · PHASE2
• A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT — RECRUITING
• Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration — RECRUITING
• Oral Metformin for Treatment of ABCA4 Retinopathy — ACTIVE_NOT_RECRUITING · PHASE1
• A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease — ACTIVE_NOT_RECRUITING · PHASE2
• A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions — NOT_YET_RECRUITING · PHASE1
• An Observational Study in Children and Adults With Stargardt Disease — ACTIVE_NOT_RECRUITING
• An Open-label, Multicenter, Two Part, Ascending Dose Followed by a Controlled Trial to Assess the Safety and Efficacy of a Subretinal Administration of AAVB-039 in Participants with Stargardt Disease (STGD1) (CELESTE) — NOT_YET_RECRUITING · PHASE2
• Phase 3, Multicenter, Randomized, Double-Masked, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Tinlarebant in the Treatment of Stargardt Disease in Adolescent Subjects — OTHER · PHASE3
• Wide Field OCTA in Ocular Diseases — NOT_YET_RECRUITING
• Inherited Retinal Diseases: Natural History and Genotype-Phenotype Correlations — NOT_YET_RECRUITING
• Feasibility and Tolerability Study of Smart Contact Lens With Healthy Subjects and Patients With Stargardt's Disease — NOT_YET_RECRUITING · NA
• ABCA4-associated Disease in Childhood and Adolescence - a Phenotype Study — COMPLETED
• Phase 1 Safety Study of ALK-001 in Healthy Volunteers — COMPLETED · PHASE1
• Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE) — ACTIVE_NOT_RECRUITING · PHASE2
• Function and Imaging Assessments for G1961E-associated Stargardt Disease — ACTIVE_NOT_RECRUITING
• Non-interventional Long Term Follow-up Study of Participants Previously Enrolled in the STARLIGHT Study — ACTIVE_NOT_RECRUITING
• Safety and Efficacy of Emixustat in Stargardt Disease — COMPLETED · PHASE3
• This is a Dose-finding Study Followed by 2-year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Adolescent Subjects With Stargardt Disease — COMPLETED · PHASE1
• Safety and Effects of a Single Intravitreal Injection of vMCO-010 Optogenetic Therapy in Subjects With Stargardt Disease — COMPLETED · PHASE2
• The Effect of Duration Between Sessions on Microperimetric Biofeedback Training in Patients With Maculopathies — COMPLETED · NA
• Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy — TERMINATED
• Pupil Dynamics and Color Vision for the Detection of Eye Diseases — COMPLETED · NA
• Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to Stargardt Disease — COMPLETED · PHASE2
• Efficacy of Acupuncture in Macular Diseases — COMPLETED · NA
• A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies — COMPLETED
• The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy — COMPLETED
• Novel Quantification Methods for Fluorescence to Detect Progression in Stargardt Disease — TERMINATED

Refine this search